CircPSMC3 Inhibits Colorectal Cancer Cell Growth and Migration by Controlling miR-31-5p/YAP/β-Catenin

Ye Jin1, Lingli Yu2, Qi Wu1

  • 1Department of General Surgery, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, 310012, China.

Abstract

Insights

Circular RNA CircPSMC3 suppresses colorectal cancer (CRC) progression by inhibiting cell proliferation, invasion, and migration. It acts as a sponge for miR-31-5p, modulating the YAP/β-catenin pathway, suggesting CircPSMC3 as a potential CRC therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Colorectal cancer (CRC) is a significant global health concern.
  • Circular RNAs (CircRNAs) play crucial roles in cancer development.
  • The specific function of CircPSMC3 in CRC remains largely unelucidated.

Purpose of the Study:

  • To investigate the regulatory role of CircPSMC3 in colorectal cancer.
  • To explore the underlying molecular mechanisms of CircPSMC3 in CRC progression.
  • To evaluate CircPSMC3 as a potential therapeutic candidate for CRC.

Main Methods:

  • Quantitative real-time PCR (RT-qPCR) for gene expression analysis.
  • Cell proliferation assays (CCK-8, EdU) and western blotting for protein expression.
  • Cell invasion and migration assays (Transwell, wound healing) and luciferase reporter assays.

Main Results:

  • CircPSMC3 expression was significantly downregulated in CRC tissues and cell lines.
  • CircPSMC3 overexpression suppressed CRC cell proliferation, invasion, and migration.
  • CircPSMC3 directly targeted miR-31-5p, modulating the YAP/β-catenin signaling pathway.

Conclusions:

  • CircPSMC3 inhibits CRC cell growth and metastasis by sponging miR-31-5p and regulating the YAP/β-catenin axis.
  • These findings highlight CircPSMC3 as a potential therapeutic biomarker and target for colorectal cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K